Prosecution Insights
Last updated: April 19, 2026

Opko Biologics Ltd.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
0
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
14123106 LONG-ACTING GLP-1/GLUCAGON RECEPTOR AGONISTS HELLMAN, KRISTINA M 1654 Non-Final OA Aug 11, 2014

Managing Opko Biologics Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month